Choi, Mi Rim

Cornelison, Robert

MacDonald, Tobey J

Rajan, Bhargavi

Rood, Brian R

Rushing, Elisabeth J

Santi, Mariarita

Smith, Courtney

Vukmanovic, Stanislav

English

PubMed

Courtney Smith

Mariarita Santi

Bhargavi Rajan

Elisabeth J Rushing

Mi Choi

Brian R Rood

Robert Cornelison

Tobey J MacDonald

Stanislav Vukmanovic

Springer - Publisher Connector

A novel role of HLA class I in the pathology of medulloblastoma

AB: Immunocytochemical demonstration of down regulation of HLA class-I molecule expression in human metastatic breast carcinoma. Clin Exp Metastasis

Activation of Akt and Erk pathways in medulloblastoma. Folia Neuropathol

Beta2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action. Cancer Res

Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res

Bourantas KL: Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia.

Burakoff SJ: The human HLAspecific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db. Immunogenetics

Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol

Childhood medulloblastoma: progress and future challenges. Brain Dev

Chung LW: Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.

Claesson MH: MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.

Classifying the medulloblastoma: insights from morphology and molecular genetics.

Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia. Leukemia

Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblasdtomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal deviation. Lab Investig

Cresswell P: Mechanisms of MHC class I–restricted antigen processing. Annu Rev Immunol

DA: Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet

Dammacco F: Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.

Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt.

Eberhart CG: c-Myc overexpression causes anaplasia in medulloblastoma. Cancer Res

EH: Serum beta-2-microglobulin levels in urological cancer.

Epidermal growth factor receptor (EGFR) expression in childhood brain tumors. In vivo

et al.: Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res

Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. Cancer Res

Expression of the W6/32 HLA epitope by cells of rat, mouse, human and other species: critical dependence on the interaction of specific MHC heavy chains with human or bovine beta 2-microglobulin.

Ferrone S: Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother

Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin. Bone Marrow Transplant

Garrido F: Analysis of HLA expression in human tumor tissues. Cancer Immunol Immunother

Giangaspero F: Pathological and molecular heterogeneity of medulloblastoma. Curr Opin Oncol

Górski A: Involvement of beta2-microglobulin in CD69 expression on T cells. Arch Immunol Ther Exp (Warsz).

Greipp PR: Prognostic factors in multiple myeloma. Hematol Oncol Clin North Am

Hagemeister FB: Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.

Hengartner H: Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Ann Rev Immunol

Interaction of class I human leukocyte antigen (HLA-I) molecules with insulin receptors and its effect on the insulin-signaling cascade. Mol Biol Cell

JR: The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol

Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med

Kishore MC: MHC class I gene expression and regulation.

LG: Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

LG: Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.

Ljungberg B: Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma. Acta Oncol

Lundqvist G: Serum beta 2-microglobulin in patients with bronchial carcinoma and controls. Cancer

Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain? Adv Anat Pathol

MN: Medulloblastoma: a population-based study of 532 cases.

Molecular characteristics of non-small cell lung cancer. Proc Nat Acad Sci USA

Momburg F: Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr Opin Immunol

Newcomb EW: Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain. Lab Investig

O: Association of HLA class I and class II antigen expression and mortality in uveal melanoma. Invest Ophthalmol Vis Sci

PC: Autocrine secreted insulin-like growth factorI stimulates MAP kinase-dependent mitogenic effects in human primitive neuroectodermal tumor/medul.loblastoma.

PE: Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules.

PE: Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction.

Peptide loading of nascent MHC class I molecules. Arch Immunol Ther Exp (Warsz).

R: TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.

Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression.

Rock KL: Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol

S: Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother

Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade.

SE: Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors. Mod Pathol

SJ: Open conformers: the hidden face of MHC-I molecules. Trends Immunol

Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain.

Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors

TJ: Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor. Mol Cancer Ther

Youngson JH: Comparison of different scoring systems for immunohistochemical staining.

Zintl F: Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med Pediatr Oncol

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2714836

A novel role of HLA class I in the pathology of medulloblastoma

Abstract

Similar works

Full text

Available Versions

Springer - Publisher Connector